TVARDI THERAPEUTICS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
TVARDI THERAPEUTICS, INC. (TVRD) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $4.75 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Investments › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2024-03-06
- 2023-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $4.75M.
- 2023-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $7.05M.
- 2023-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $9.07M.
- 2022-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $11.35M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2023-09-30 | $4.75M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $7.05M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $9.07M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.35M 10-K · filed 2024-03-06 |
| 2022-09-30 | $23.92M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $47.17M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $68.46M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $69.75M 10-K · filed 2023-03-06 |
| 2021-09-30 | $49.22M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $52.22M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $56.73M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $70.56M 10-K · filed 2022-03-01 |
| 2019-12-31 | $63.16M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |